Lincoln Pharmaceuticals Ltd.
LINCOLN Share PricePharmaceuticals & Drugs
₹495.1
-8.1 (-1.6%)
As on December 4, 2025
Exchange Scrips: BSE531633NSELINCOLNISININE405C01035
Market Cap ₹ 1,000 Cr
P/E Ratio 12.04
Dividend Yield 0.04 %
Performance
Market performance
Open501
High501.85
Volumes12,919
Prev495.1
Low494
As on2025-12-04
Historical performance
1 Year High979.5
3 Year High979.5
5 Year High979.5
1 Year Low490
3 Year Low300
5 Year Low211.1
Fundamentals
Company Valuation
Market Cap (₹Cr)
1,000
Face Value (₹)
10
P/E Ratio
12.04
Dividend Yield
0.04 %
Investment Returns
1 Year
-45.8%
3 Years
46.4%
5 Years
113.7%
10 Years
N/A
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 503.51 | Bearish |
| 10-DMA | 511.73 | Bearish |
| 20-DMA | 519.22 | Bearish |
| 50-DMA | 525.61 | Bearish |
| 100-DMA | 538.08 | Bearish |
| 200-DMA | 551.73 | Bearish |
Shareholding Pattern
| Field | Sep-2025 | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 |
|---|---|---|---|---|---|
| Promoters | 25 | 25 | 25 | 25 | 25 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 25 | 25 | 25 | 25 | 25 |
| Public Investors | 32345 | 31759 | 31842 | 31823 | 31305 |
| Government | --- | --- | --- | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 12.04.
- 3Y Stock Price CAGR of the stock is 12.4.
- The stock has a beta of 1.1.
- In the last financial year, the company had an EBITDA of ₹1240 Million.
- The company generated revenue of ₹6232 Million in the previous financial year.
Lincoln Pharmaceuticals Ltd.
495.1-8.1 (-1.6%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 536432.1
No. of Shares: 1083 (Approx)
Performance:-46.4%
P/L: ₹-463567.9
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
